Rimac leaving Sagimet as CFO

Anthony Rimac will step down as CFO of Sagimet Biosciences Inc. (NASDAQ:SGMT) for personal reasons, effective Jan. 31. Gaeton Biscardi, managing director of financial advisory firm Stout Risius Ross LLC, will serve as interim VP of finance, and Stout’s Joe Oriti will provide consulting services. Sagimet added that, contingent upon board approval, it plans to name Oriti as interim principal financial officer once Rimac leaves. 

T cell engager company Harpoon Therapeutics Inc. (NASDAQ:HARP) hired James Bucher as chief legal officer and promoted Wendy Chang to chief people officer. Bucher was EVP, general counsel and head of HR at Eliem Therapeutics Inc. (NASDAQ:ELYM); Chang joined Harpoon in 2022 as SVP of HR. ...